Biomanufacturing Team

Becky Butler Cap

Chief Operating Officer, GenCure
Senior Vice President, BioBridge Global

Becky Cap, a 25-year veteran of the life sciences industry, was named chief operating officer of San Antonio-based GenCure in February 2016. GenCure, a subsidiary of BioBridge Global, is focused on providing process development and cGMP manufacturing services. Cap drove the intra-preneurial development and integration of these new service lines for BioBridge Global and supported the extension of other business unit offerings into the cell therapy and regenerative medicine space. GenCure’s mission is to realize the potential of donated human cells and tissue to save and enhance lives.

Cap, a native of Texas, earned a bachelor’s degree from Harvard University and an MBA from Boston University’s Questrom School of Management. She began her career at Dana-Farber Cancer Institute in Boston, where she worked on early trials exploring the benefits of hematologic stem cell transplant for breast cancer and the effects of growth factors in high-dose chemotherapy trials.

Her move to industry began at Eidetics, a consulting firm focused on informing biomedical product development support. She supported US and global development and strategic marketing efforts for chemotherapeutics, leading monoclonal antibodies, tyrosine kinase inhibitors and immuno-oncology agents, including PD-1 and PDL-1 inhibitors. Her expertise was honed as Oncology became an active and competitive market in which physicians and patients had multiple treatment options available to them for their cancers. She started one of the first Oncology Consulting Practices in this strategic marketing and market research space. She also has run her own consulting firm and worked with a number of local startups in the San Antonio community.

Cap has provided strategic guidance for the development of pharmaceuticals and medical devices, both in large, established firms and early stage ventures. She has provided extensive entrepreneurial executive coaching and mentoring. She is an active member of local and national committees on Regenerative Medicine and Cell Therapy, two private company Boards of Directors and the Governing Committee for Seton Home. Additionally, Cap is a co-founder and founding president of San Antonio TechBoosters, a 501(c)6 organization established to mentor student entrepreneurs.

Read more

Michael J. Fiske

Vice President, Biomanufacturing

Mike Fiske has more than 30 years in the biotechnology industry as a protein chemist, analytical biochemist, process development scientist and cGMP operations manager. He serves as Vice President, Biomanufacturing at GenCure, which operates a multi-use, cGMP-compliant, contract manufacturing facility designed for the development and manufacture of advanced therapies.

He has extensive background in cGMP compliance, including manufacturing facility design, construction and validation. Mike also has extensive experience in biologics process development, analytical test method development, and validation, as well as cGMP manufacturing and QC release testing of clinical-grade biologics including vaccines, protein therapeutics and cell therapy products.

As Vice President, Mike is responsible for the ongoing facility operations including new facility construction and validation, technology transfer, clinical-scale process and analytical methods development, cGMP manufacturing and QC testing of preclinical and clinical-grade cell-based products. He also provides assistance to clients with preparation of regulatory documents and interactions with regulatory agencies as needed.

Read more

Christie Malone

Business Development Director

A 25-year industry veteran, Christie Malone is the Business Development Director at GenCure. Malone focuses on advancing the organization’s strategic collaborations with not only therapeutic cell and cell & gene therapy companies in every stage of the product development pipeline, but also the companies that provide tools to facilitate clinical product manufacturing.

Since joining GenCure in 2017, Malone has established GenCure as a preferred contract development and manufacturing organization for the cell and gene therapy marketplace, ensuring client satisfaction and enduring trust as a long-term partner.

Her current role relies on more than 2 decades experience in transfusion medicine, which includes pediatric transfusion practice, blood center immunohematology and infectious disease testing. She also has experience in sales and marketing of 510(k)-regulated, closed-system medical devices.

Read more